The Lynne Cohen Foundation For Ovarian Cancer Research
MENU OPTIONS
HOME
OUR MISSION
OUR STORY
PRESS ROOM
LCF BOARDS
THE RESEARCH
WARNING SIGNS
CLINICAL TRIALS
PREVENTION CLINICS
SPONSORS
CONFERENCES
EVENTS
KICKIN' CANCER
TRIBUTE FUNDS
WAYS TO GIVE
RESOURCES
SHOPPING
CONTACT US
The Lynne Cohen Foundation In The News
THE LYNNE COHEN PREVENTIVE CARE symposium FOR WOMEN'S CANCERS FUNDED AT USC/NORRIS CANCER CENTER

LOS ANGELES, CA, APRIL 9, 2001 - The Lynne Cohen Foundation for Ovarian Cancer Research has made a five-year, $500,000 grant to USC/Norris Comprehensive Cancer Center in Los Angeles to fund The Lynne Cohen Preventive Care symposium for Women's Cancers.

The pilot project will be a unique screening and Clinical care service for women at high risk, or with increased risk, for ovarian, breast and other women's cancers (e.g., endometrial, cervical, tubal). Lynda Roman, MD, Assistant Professor of Obstetrics and Gynecology and Chief of Gynecologic Oncology, and Jim Waisman, MD, Associate Professor of Medical Oncology, will co-direct the symposium, which is housed within the Harold E. and Henrietta C. Lee Breast Center at USC/Norris Cancer Hospital. The Lee Breast Center unites the latest medical technology with Clinical expertise, emotional support and compassionate care. Women referred to the Lynne Cohen symposium will receive state-of-the-art preventive care and early detection screening.

A thorough risk assessment, in-depth medical history, as well as routine and advanced screening examinations (physical and laboratory) will be offered to all participants. Women who are determined to have increased risk will receive continued monitoring and access to Clinical trials. The program is geared to women having any of the following: A BRCA 1 or 2 mutation; a first-degree (mother, sister, daughter) relative with breast and/or ovarian cancer or multiple family members with breast and/or ovarian cancer; a close (not necessarily first-degree) family relative diagnosed with early-age-onset breast or ovarian cancer; a breast biopsy with atypical cells or lobular carcinoma in-situ; a diagnosis of breast or ovarian cancer, one of which increases the risk for the other; or Ashkenazi Jewish descent.

The project will provide the women in the study with a focused educational component, which will help them to make informed choices about risk reduction, genetic testing, preventive measures, and lifestyle issues. The symposium will also offer advanced and investigational screening methods for early detection as well as access to Clinical trials in cancer symposium and treatment at USC/Norris Cancer Center.

The Lynne Cohen Foundation for Ovarian Cancer Research is a unique nonprofit foundation that raises funds for cutting-edge medical research in the women's healthcare field. Created in 1998 in memory of Lynne Cohen by her three daughters (in their twenties), The Lynne Cohen Foundation is dedicated to finding an early detection test for ovarian cancer, to establishing high risk symposiums for women with family members who have been diagnosed with ovarian and/or breast cancer, and to finding better Clinical treatments for women struggling with the disease. The sisters' mission is to keep their mom's memory alive by helping other women in her name. A recent recipient of the Reader's Digest 2001 Health Heroes Award, Foundation President Amy Cohen, says, "We are committed to making an impact on women's healthcare - to changing the outcome for every woman who receives a diagnosis of ovarian cancer - to helping as many women as possible, at every conceivable stage of disease, including preventive care."

Ovarian cancer is considered the most deadly gynecological cancer, striking 26,000 women and killing approximately 14,000 every year in the United States. Presently, there is no early detection test for ovarian cancer. As a result, 75 percent of the women diagnosed have late stage disease and only a 12 percent chance of surviving five years. The Lynne Cohen Foundation is entering the arena of preventive care precisely because of its desire to change those statistics. Earlier this year, the Foundation funded The Lynne Cohen Cancer Screening & symposium Project for High Risk Women at NYU Medical Center in New York.

For more information, please contact:
Trudy Harris
The Lynne Cohen Foundation
310.571.9126

Brenda Maceo
USC/Norris Cancer Center
323.442.2830

BACK TO PRESS ROOM MAIN
 
© 2005 The Lynne Cohen Foundation For Ovarian Cancer Research. All Rights Reserved. Designed by Amethyst Visions.